AU2007353773A1 - Plant-made West Nile virus (WNV) vaccines, vectors and plant codon optimized sequences - Google Patents

Info

Publication number

AU2007353773A1

AU2007353773A1 AU2007353773A AU2007353773A AU2007353773A1 AU 2007353773 A1 AU2007353773 A1 AU 2007353773A1 AU 2007353773 A AU2007353773 A AU 2007353773A AU 2007353773 A AU2007353773 A AU 2007353773A AU 2007353773 A1 AU2007353773 A1 AU 2007353773A1

Authority

AU

Australia

Prior art keywords

seq

polypeptide

fragment

set forth

sequence

Prior art date

2006-12-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 241000710886 West Nile virus Species 0.000 title claims description 180
• 239000013598 vector Substances 0.000 title claims description 128
• 229960005486 vaccine Drugs 0.000 title description 74
• 108020004705 Codon Proteins 0.000 title description 49
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 336
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 268
• 239000012634 fragment Substances 0.000 claims description 258
• 229920001184 polypeptide Polymers 0.000 claims description 246
• 210000004027 cell Anatomy 0.000 claims description 183
• 238000000034 method Methods 0.000 claims description 147
• 241000196324 Embryophyta Species 0.000 claims description 142
• 102000040430 polynucleotide Human genes 0.000 claims description 103
• 108091033319 polynucleotide Proteins 0.000 claims description 103
• 239000002157 polynucleotide Substances 0.000 claims description 103
• 150000001413 amino acids Chemical class 0.000 claims description 100
• 230000014509 gene expression Effects 0.000 claims description 87
• 239000000427 antigen Substances 0.000 claims description 79
• 239000000203 mixture Substances 0.000 claims description 61
• 238000003556 assay Methods 0.000 claims description 52
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 49
• 239000000523 sample Substances 0.000 claims description 47
• 230000003472 neutralizing effect Effects 0.000 claims description 40
• 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 39
• 241000700605 Viruses Species 0.000 claims description 39
• 239000002773 nucleotide Substances 0.000 claims description 36
• 125000003729 nucleotide group Chemical group 0.000 claims description 36
• 239000002671 adjuvant Substances 0.000 claims description 33
• 230000028993 immune response Effects 0.000 claims description 27
• 150000007523 nucleic acids Chemical group 0.000 claims description 26
• 239000000872 buffer Substances 0.000 claims description 25
• 230000002068 genetic effect Effects 0.000 claims description 23
• 241001233957 eudicotyledons Species 0.000 claims description 22
• 230000005875 antibody response Effects 0.000 claims description 19
• 238000004519 manufacturing process Methods 0.000 claims description 19
• 238000002965 ELISA Methods 0.000 claims description 18
• 230000009261 transgenic effect Effects 0.000 claims description 17
• 208000015181 infectious disease Diseases 0.000 claims description 16
• 239000000463 material Substances 0.000 claims description 15
• 230000002441 reversible effect Effects 0.000 claims description 15
• 230000002458 infectious effect Effects 0.000 claims description 14
• 239000003550 marker Substances 0.000 claims description 13
• 238000001262 western blot Methods 0.000 claims description 13
• 230000015572 biosynthetic process Effects 0.000 claims description 12
• 239000013603 viral vector Substances 0.000 claims description 12
• 125000001433 C-terminal amino-acid group Chemical group 0.000 claims description 11
• 241001465754 Metazoa Species 0.000 claims description 11
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 11
• 230000001580 bacterial effect Effects 0.000 claims description 11
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 10
• 230000004044 response Effects 0.000 claims description 10
• 230000000295 complement effect Effects 0.000 claims description 7
• 238000003018 immunoassay Methods 0.000 claims description 6
• 238000003127 radioimmunoassay Methods 0.000 claims description 6
• 230000001131 transforming effect Effects 0.000 claims description 6
• 241000209510 Liliopsida Species 0.000 claims description 5
• 230000001413 cellular effect Effects 0.000 claims description 5
• 238000000159 protein binding assay Methods 0.000 claims description 5
• 238000009825 accumulation Methods 0.000 claims description 4
• 238000012258 culturing Methods 0.000 claims description 4
• 230000001939 inductive effect Effects 0.000 claims description 4
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
• 241000208125 Nicotiana Species 0.000 claims description 3
• 230000003053 immunization Effects 0.000 claims description 3
• 210000004962 mammalian cell Anatomy 0.000 claims description 3
• 238000007818 agglutination assay Methods 0.000 claims description 2
• 210000003527 eukaryotic cell Anatomy 0.000 claims description 2
• 238000001114 immunoprecipitation Methods 0.000 claims description 2
• 230000002480 immunoprotective effect Effects 0.000 claims 5
• 210000001236 prokaryotic cell Anatomy 0.000 claims 2
• 230000035755 proliferation Effects 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 description 192
• 235000001014 amino acid Nutrition 0.000 description 100
• 102000004169 proteins and genes Human genes 0.000 description 100
• 229940024606 amino acid Drugs 0.000 description 99
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 99
• 235000018102 proteins Nutrition 0.000 description 94
• 239000002253 acid Substances 0.000 description 82
• 108091007433 antigens Proteins 0.000 description 75
• 102000036639 antigens Human genes 0.000 description 75
• 108020005345 3' Untranslated Regions Proteins 0.000 description 66
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 63
• 108020004414 DNA Proteins 0.000 description 58
• 150000007513 acids Chemical class 0.000 description 57
• 101710204837 Envelope small membrane protein Proteins 0.000 description 53
• 101710145006 Lysis protein Proteins 0.000 description 53
• 241000283086 Equidae Species 0.000 description 46
• 210000002966 serum Anatomy 0.000 description 45
• 239000000243 solution Substances 0.000 description 41
• 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 40
• 244000061176 Nicotiana tabacum Species 0.000 description 37
• 108010055615 Zein Proteins 0.000 description 34
• 230000008685 targeting Effects 0.000 description 34
• 108091026890 Coding region Proteins 0.000 description 33
• 229920002494 Zein Polymers 0.000 description 33
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
• 229940093612 zein Drugs 0.000 description 33
• 239000005019 zein Substances 0.000 description 33
• 241001515826 Cassava vein mosaic virus Species 0.000 description 30
• 241000699670 Mus sp. Species 0.000 description 29
• 102000037865 fusion proteins Human genes 0.000 description 29
• 108020001507 fusion proteins Proteins 0.000 description 29
• 239000013612 plasmid Substances 0.000 description 25
• 230000008569 process Effects 0.000 description 25
• 230000014759 maintenance of location Effects 0.000 description 24
• 239000002609 medium Substances 0.000 description 23
• 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 23
• 239000000725 suspension Substances 0.000 description 23
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 22
• 238000006386 neutralization reaction Methods 0.000 description 22
• 230000009466 transformation Effects 0.000 description 22
• 238000003752 polymerase chain reaction Methods 0.000 description 21
• 239000012528 membrane Substances 0.000 description 20
• 238000010367 cloning Methods 0.000 description 19
• 102000039446 nucleic acids Human genes 0.000 description 19
• 108020004707 nucleic acids Proteins 0.000 description 19
• 230000014616 translation Effects 0.000 description 19
• 206010020649 Hyperkeratosis Diseases 0.000 description 18
• 230000004988 N-glycosylation Effects 0.000 description 18
• 238000009396 hybridization Methods 0.000 description 18
• 108020004999 messenger RNA Proteins 0.000 description 18
• -1 polyethylene Polymers 0.000 description 18
• 239000000047 product Substances 0.000 description 18
• 238000002255 vaccination Methods 0.000 description 18
• 125000003275 alpha amino acid group Chemical group 0.000 description 17
• 238000011282 treatment Methods 0.000 description 17
• 238000013519 translation Methods 0.000 description 16
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 15
• 238000004113 cell culture Methods 0.000 description 15
• 238000001514 detection method Methods 0.000 description 15
• 238000010790 dilution Methods 0.000 description 15
• 239000012895 dilution Substances 0.000 description 15
• 238000000855 fermentation Methods 0.000 description 15
• 230000004151 fermentation Effects 0.000 description 15
• 238000009472 formulation Methods 0.000 description 15
• 210000004369 blood Anatomy 0.000 description 14
• 239000008280 blood Substances 0.000 description 14
• 230000001681 protective effect Effects 0.000 description 14
• 239000006228 supernatant Substances 0.000 description 14
• 108010076504 Protein Sorting Signals Proteins 0.000 description 13
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
• 238000012360 testing method Methods 0.000 description 13
• 238000013518 transcription Methods 0.000 description 13
• 230000035897 transcription Effects 0.000 description 13
• 241000589158 Agrobacterium Species 0.000 description 12
• 102100034349 Integrase Human genes 0.000 description 12
• 238000004458 analytical method Methods 0.000 description 12
• 238000013461 design Methods 0.000 description 12
• 210000002845 virion Anatomy 0.000 description 12
• 108700026244 Open Reading Frames Proteins 0.000 description 11
• 239000008188 pellet Substances 0.000 description 11
• 239000002953 phosphate buffered saline Substances 0.000 description 11
• 210000003501 vero cell Anatomy 0.000 description 11
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 10
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 10
• 230000000120 cytopathologic effect Effects 0.000 description 10
• 206010014599 encephalitis Diseases 0.000 description 10
• 230000013595 glycosylation Effects 0.000 description 10
• 238000006206 glycosylation reaction Methods 0.000 description 10
• 241000283073 Equus caballus Species 0.000 description 9
• 241000699666 Mus <mouse, genus> Species 0.000 description 9
• 230000004071 biological effect Effects 0.000 description 9
• 201000010099 disease Diseases 0.000 description 9
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
• 239000013604 expression vector Substances 0.000 description 9
• 230000001404 mediated effect Effects 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 8
• 102000053602 DNA Human genes 0.000 description 8
• 241000710831 Flavivirus Species 0.000 description 8
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 8
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 8
• 102000003960 Ligases Human genes 0.000 description 8
• 108090000364 Ligases Proteins 0.000 description 8
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
• 229920002125 Sokalan® Polymers 0.000 description 8
• 210000001744 T-lymphocyte Anatomy 0.000 description 8
• 238000006243 chemical reaction Methods 0.000 description 8
• 230000000694 effects Effects 0.000 description 8
• 238000005516 engineering process Methods 0.000 description 8
• 239000007788 liquid Substances 0.000 description 8
• 239000011159 matrix material Substances 0.000 description 8
• 239000011780 sodium chloride Substances 0.000 description 8
• 239000008223 sterile water Substances 0.000 description 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
• 108010041986 DNA Vaccines Proteins 0.000 description 7
• 229940021995 DNA vaccine Drugs 0.000 description 7
• 241000588724 Escherichia coli Species 0.000 description 7
• 101000833492 Homo sapiens Jouberin Proteins 0.000 description 7
• 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 7
• 102100024407 Jouberin Human genes 0.000 description 7
• 241000700618 Vaccinia virus Species 0.000 description 7
• 238000005119 centrifugation Methods 0.000 description 7
• 238000004520 electroporation Methods 0.000 description 7
• 239000012091 fetal bovine serum Substances 0.000 description 7
• 238000003306 harvesting Methods 0.000 description 7
• 238000005259 measurement Methods 0.000 description 7
• 230000004048 modification Effects 0.000 description 7
• 238000012986 modification Methods 0.000 description 7
• 230000035772 mutation Effects 0.000 description 7
• 238000012545 processing Methods 0.000 description 7
• 230000001105 regulatory effect Effects 0.000 description 7
• 239000007787 solid Substances 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 238000013190 sterility testing Methods 0.000 description 7
• 239000011550 stock solution Substances 0.000 description 7
• 238000012546 transfer Methods 0.000 description 7
• 230000003612 virological effect Effects 0.000 description 7
• 101710115267 ATP synthase protein MI25 Proteins 0.000 description 6
• 241000271566 Aves Species 0.000 description 6
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
• 101710091045 Envelope protein Proteins 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• 239000007993 MOPS buffer Substances 0.000 description 6
• 101710188315 Protein X Proteins 0.000 description 6
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
• 241000710771 Tick-borne encephalitis virus Species 0.000 description 6
• OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 6
• 238000003491 array Methods 0.000 description 6
• 230000000903 blocking effect Effects 0.000 description 6
• 238000010276 construction Methods 0.000 description 6
• UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 6
• 238000006073 displacement reaction Methods 0.000 description 6
• 229940088598 enzyme Drugs 0.000 description 6
• 230000012010 growth Effects 0.000 description 6
• 230000000977 initiatory effect Effects 0.000 description 6
• 230000000670 limiting effect Effects 0.000 description 6
• 208000017629 mild encephalitis Diseases 0.000 description 6
• 238000000746 purification Methods 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• 210000001519 tissue Anatomy 0.000 description 6
• 230000002103 transcriptional effect Effects 0.000 description 6
• WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 5
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
• 101000800755 Naja oxiana Alpha-elapitoxin-Nno2a Proteins 0.000 description 5
• 240000008042 Zea mays Species 0.000 description 5
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
• 210000000170 cell membrane Anatomy 0.000 description 5
• 210000002421 cell wall Anatomy 0.000 description 5
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• KSDGSKVLUHKDAL-UHFFFAOYSA-L disodium;3-[2-carboxylatoethyl(dodecyl)amino]propanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCN(CCC([O-])=O)CCC([O-])=O KSDGSKVLUHKDAL-UHFFFAOYSA-L 0.000 description 5
• 239000008103 glucose Substances 0.000 description 5
• 230000002962 histologic effect Effects 0.000 description 5
• 230000002163 immunogen Effects 0.000 description 5
• 238000011534 incubation Methods 0.000 description 5
• 230000036512 infertility Effects 0.000 description 5
• 238000003780 insertion Methods 0.000 description 5
• 230000037431 insertion Effects 0.000 description 5
• SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 5
• 229910052760 oxygen Inorganic materials 0.000 description 5
• 239000001301 oxygen Substances 0.000 description 5
• 239000013600 plasmid vector Substances 0.000 description 5
• 229920003023 plastic Polymers 0.000 description 5
• 239000004033 plastic Substances 0.000 description 5
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
• 239000013641 positive control Substances 0.000 description 5
• 210000001938 protoplast Anatomy 0.000 description 5
• 230000002285 radioactive effect Effects 0.000 description 5
• 238000011084 recovery Methods 0.000 description 5
• 230000010076 replication Effects 0.000 description 5
• 108091008146 restriction endonucleases Proteins 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
• 108020003589 5' Untranslated Regions Proteins 0.000 description 4
• 101100028213 Caenorhabditis elegans osm-3 gene Proteins 0.000 description 4
• 241000283707 Capra Species 0.000 description 4
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
• 108700010070 Codon Usage Proteins 0.000 description 4
• 101710121417 Envelope glycoprotein Proteins 0.000 description 4
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 4
• 108700001094 Plant Genes Proteins 0.000 description 4
• 108020004511 Recombinant DNA Proteins 0.000 description 4
• 108091081024 Start codon Proteins 0.000 description 4
• 229930006000 Sucrose Natural products 0.000 description 4
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
• 101000623262 Trypanosoma brucei brucei Uncharacterized 22 kDa protein in aldolase locus Proteins 0.000 description 4
• 101710134973 Uncharacterized 9.7 kDa protein in cox-rep intergenic region Proteins 0.000 description 4
• 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
• 230000002159 abnormal effect Effects 0.000 description 4
• 238000013019 agitation Methods 0.000 description 4
• 230000003321 amplification Effects 0.000 description 4
• 239000011324 bead Substances 0.000 description 4
• 239000007613 bennett's agar Substances 0.000 description 4
• 239000012472 biological sample Substances 0.000 description 4
• 238000009529 body temperature measurement Methods 0.000 description 4
• 210000004899 c-terminal region Anatomy 0.000 description 4
• 229940041514 candida albicans extract Drugs 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 239000003599 detergent Substances 0.000 description 4
• 230000029087 digestion Effects 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 230000003308 immunostimulating effect Effects 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 230000006698 induction Effects 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 239000012139 lysis buffer Substances 0.000 description 4
• 235000009973 maize Nutrition 0.000 description 4
• 239000013642 negative control Substances 0.000 description 4
• 238000003199 nucleic acid amplification method Methods 0.000 description 4
• 239000000419 plant extract Substances 0.000 description 4
• 238000004445 quantitative analysis Methods 0.000 description 4
• 230000009257 reactivity Effects 0.000 description 4
• 230000008707 rearrangement Effects 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 150000003839 salts Chemical class 0.000 description 4
• 238000013341 scale-up Methods 0.000 description 4
• 238000012163 sequencing technique Methods 0.000 description 4
• 239000011734 sodium Substances 0.000 description 4
• 238000003756 stirring Methods 0.000 description 4
• 239000005720 sucrose Substances 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• 239000012138 yeast extract Substances 0.000 description 4
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
• 229920001817 Agar Polymers 0.000 description 3
• 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 3
• 102100036845 C-C motif chemokine 22 Human genes 0.000 description 3
• 241000286222 Centrocercus Species 0.000 description 3
• 238000000018 DNA microarray Methods 0.000 description 3
• 241000725619 Dengue virus Species 0.000 description 3
• 101000947616 Enterobacteria phage PRD1 Putative uncharacterized 4.5 kDa protein in genes IX-XX intergenic region Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
• 102000053187 Glucuronidase Human genes 0.000 description 3
• 108010060309 Glucuronidase Proteins 0.000 description 3
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 101710085938 Matrix protein Proteins 0.000 description 3
• 101710127721 Membrane protein Proteins 0.000 description 3
• 241000710908 Murray Valley encephalitis virus Species 0.000 description 3
• 239000001888 Peptone Substances 0.000 description 3
• 108010080698 Peptones Proteins 0.000 description 3
• 108010076039 Polyproteins Proteins 0.000 description 3
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
• 108020005038 Terminator Codon Proteins 0.000 description 3
• 206010058874 Viraemia Diseases 0.000 description 3
• 239000008272 agar Substances 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 230000000692 anti-sense effect Effects 0.000 description 3
• 230000000890 antigenic effect Effects 0.000 description 3
• 238000000376 autoradiography Methods 0.000 description 3
• GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 238000004422 calculation algorithm Methods 0.000 description 3
• 229910002091 carbon monoxide Inorganic materials 0.000 description 3
• 239000006285 cell suspension Substances 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 239000000539 dimer Substances 0.000 description 3
• 238000009826 distribution Methods 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 238000004108 freeze drying Methods 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 238000001502 gel electrophoresis Methods 0.000 description 3
• 239000011521 glass Substances 0.000 description 3
• 230000002779 inactivation Effects 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 239000006166 lysate Substances 0.000 description 3
• 238000012423 maintenance Methods 0.000 description 3
• 238000002844 melting Methods 0.000 description 3
• 230000008018 melting Effects 0.000 description 3
• 238000002941 microtiter virus yield reduction assay Methods 0.000 description 3
• 239000002245 particle Substances 0.000 description 3
• 235000019319 peptone Nutrition 0.000 description 3
• 238000007747 plating Methods 0.000 description 3
• 229920000656 polylysine Polymers 0.000 description 3
• 230000009465 prokaryotic expression Effects 0.000 description 3
• 239000005297 pyrex Substances 0.000 description 3
• 239000002994 raw material Substances 0.000 description 3
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
• 238000000527 sonication Methods 0.000 description 3
• 229910001220 stainless steel Inorganic materials 0.000 description 3
• 239000010935 stainless steel Substances 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 238000004114 suspension culture Methods 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 238000004448 titration Methods 0.000 description 3
• 238000011144 upstream manufacturing Methods 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• DPWDPEVGACCWTC-SRVKXCTJSA-N Asn-Tyr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O DPWDPEVGACCWTC-SRVKXCTJSA-N 0.000 description 2
• 241000972773 Aulopiformes Species 0.000 description 2
• 101000666833 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.8 kDa protein in FGF-VUBI intergenic region Proteins 0.000 description 2
• 101000977027 Azospirillum brasilense Uncharacterized protein in nodG 5'region Proteins 0.000 description 2
• 101000962005 Bacillus thuringiensis Uncharacterized 23.6 kDa protein Proteins 0.000 description 2
• BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
• 102100036842 C-C motif chemokine 19 Human genes 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 2
• 102100036846 C-C motif chemokine 21 Human genes 0.000 description 2
• 102100036849 C-C motif chemokine 24 Human genes 0.000 description 2
• 102100025250 C-X-C motif chemokine 14 Human genes 0.000 description 2
• 241000701489 Cauliflower mosaic virus Species 0.000 description 2
• 108010078239 Chemokine CX3CL1 Proteins 0.000 description 2
• 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 2
• 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 2
• 108020004635 Complementary DNA Proteins 0.000 description 2
• 241000195493 Cryptophyta Species 0.000 description 2
• 239000003298 DNA probe Substances 0.000 description 2
• 208000001490 Dengue Diseases 0.000 description 2
• 206010012310 Dengue fever Diseases 0.000 description 2
• 101000785191 Drosophila melanogaster Uncharacterized 50 kDa protein in type I retrotransposable element R1DM Proteins 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• 101000747704 Enterobacteria phage N4 Uncharacterized protein Gp1 Proteins 0.000 description 2
• 101000861206 Enterococcus faecalis (strain ATCC 700802 / V583) Uncharacterized protein EF_A0048 Proteins 0.000 description 2
• 101000769180 Escherichia coli Uncharacterized 11.1 kDa protein Proteins 0.000 description 2
• 229920001917 Ficoll Polymers 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 2
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 2
• 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 2
• 101000713083 Homo sapiens C-C motif chemokine 22 Proteins 0.000 description 2
• 101000858068 Homo sapiens C-X-C motif chemokine 14 Proteins 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 241000710842 Japanese encephalitis virus Species 0.000 description 2
• 241000235058 Komagataella pastoris Species 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• 101000976301 Leptospira interrogans Uncharacterized 35 kDa protein in sph 3'region Proteins 0.000 description 2
• 102000004058 Leukemia inhibitory factor Human genes 0.000 description 2
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 2
• 102100035304 Lymphotactin Human genes 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 101000658690 Neisseria meningitidis serogroup B Transposase for insertion sequence element IS1106 Proteins 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
• 108010038807 Oligopeptides Proteins 0.000 description 2
• 102000015636 Oligopeptides Human genes 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 241000070023 Phoenicopterus roseus Species 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 108010068086 Polyubiquitin Proteins 0.000 description 2
• 102100037935 Polyubiquitin-C Human genes 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• 101000748660 Pseudomonas savastanoi Uncharacterized 21 kDa protein in iaaL 5'region Proteins 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 101000584469 Rice tungro bacilliform virus (isolate Philippines) Protein P1 Proteins 0.000 description 2
• 241000714474 Rous sarcoma virus Species 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• 101000818096 Spirochaeta aurantia Uncharacterized 15.5 kDa protein in trpE 3'region Proteins 0.000 description 2
• 241000710888 St. Louis encephalitis virus Species 0.000 description 2
• 101000766081 Streptomyces ambofaciens Uncharacterized HTH-type transcriptional regulator in unstable DNA locus Proteins 0.000 description 2
• 101000804403 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HIT-like protein Synpcc7942_1390 Proteins 0.000 description 2
• 101000750910 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HTH-type transcriptional regulator Synpcc7942_2319 Proteins 0.000 description 2
• 101000644897 Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) Uncharacterized protein SYNPCC7002_B0001 Proteins 0.000 description 2
• 108700005078 Synthetic Genes Proteins 0.000 description 2
• 239000004809 Teflon Substances 0.000 description 2
• 229920006362 Teflon® Polymers 0.000 description 2
• 108020004440 Thymidine kinase Proteins 0.000 description 2
• 108010009583 Transforming Growth Factors Proteins 0.000 description 2
• 102000009618 Transforming Growth Factors Human genes 0.000 description 2
• 239000013504 Triton X-100 Substances 0.000 description 2
• 229920004890 Triton X-100 Polymers 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 101710183681 Uncharacterized protein 7 Proteins 0.000 description 2
• 108091023045 Untranslated Region Proteins 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 108010067390 Viral Proteins Proteins 0.000 description 2
• 101000916336 Xenopus laevis Transposon TX1 uncharacterized 82 kDa protein Proteins 0.000 description 2
• 208000003152 Yellow Fever Diseases 0.000 description 2
• 101001000760 Zea mays Putative Pol polyprotein from transposon element Bs1 Proteins 0.000 description 2
• 101000678262 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 65 kDa protein Proteins 0.000 description 2
• 210000001015 abdomen Anatomy 0.000 description 2
• 230000003187 abdominal effect Effects 0.000 description 2
• 230000002411 adverse Effects 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 230000002238 attenuated effect Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 238000010804 cDNA synthesis Methods 0.000 description 2
• FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
• 229960003669 carbenicillin Drugs 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 235000011089 carbon dioxide Nutrition 0.000 description 2
• 238000012754 cardiac puncture Methods 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 210000003850 cellular structure Anatomy 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 238000005352 clarification Methods 0.000 description 2
• 239000000356 contaminant Substances 0.000 description 2
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 208000025729 dengue disease Diseases 0.000 description 2
• 230000001627 detrimental effect Effects 0.000 description 2
• 239000012897 dilution medium Substances 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 210000002257 embryonic structure Anatomy 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 210000001163 endosome Anatomy 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 238000001476 gene delivery Methods 0.000 description 2
• 238000010353 genetic engineering Methods 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 210000002443 helper t lymphocyte Anatomy 0.000 description 2
• 238000000265 homogenisation Methods 0.000 description 2
• 210000004408 hybridoma Anatomy 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 208000014674 injury Diseases 0.000 description 2
• 238000011081 inoculation Methods 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 230000034217 membrane fusion Effects 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 238000000520 microinjection Methods 0.000 description 2
• 239000011859 microparticle Substances 0.000 description 2
• 238000012544 monitoring process Methods 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 239000002751 oligonucleotide probe Substances 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 108010079892 phosphoglycerol kinase Proteins 0.000 description 2
• 230000000704 physical effect Effects 0.000 description 2
• 238000004161 plant tissue culture Methods 0.000 description 2
• 229920001084 poly(chloroprene) Polymers 0.000 description 2
• 230000008488 polyadenylation Effects 0.000 description 2
• 230000000241 respiratory effect Effects 0.000 description 2
• 235000019515 salmon Nutrition 0.000 description 2
• 229920006395 saturated elastomer Polymers 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 239000013049 sediment Substances 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 230000000405 serological effect Effects 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 230000000392 somatic effect Effects 0.000 description 2
• UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 239000012134 supernatant fraction Substances 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 238000010381 tandem affinity purification Methods 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 230000005945 translocation Effects 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 241000701447 unidentified baculovirus Species 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• 239000011534 wash buffer Substances 0.000 description 2
• TYKASZBHFXBROF-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-(2,5-dioxopyrrol-1-yl)acetate Chemical compound O=C1CCC(=O)N1OC(=O)CN1C(=O)C=CC1=O TYKASZBHFXBROF-UHFFFAOYSA-N 0.000 description 1
• YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• 101150072531 10 gene Proteins 0.000 description 1
• 101150029062 15 gene Proteins 0.000 description 1
• CZIHNRWJTSTCEX-UHFFFAOYSA-N 2 Acetylaminofluorene Chemical compound C1=CC=C2C3=CC=C(NC(=O)C)C=C3CC2=C1 CZIHNRWJTSTCEX-UHFFFAOYSA-N 0.000 description 1
• 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
• XYYUAOIALFMRGY-UHFFFAOYSA-N 3-[2-carboxyethyl(dodecyl)amino]propanoic acid Chemical compound CCCCCCCCCCCCN(CCC(O)=O)CCC(O)=O XYYUAOIALFMRGY-UHFFFAOYSA-N 0.000 description 1
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
• QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
• CJRJTCMSQLEPFQ-UHFFFAOYSA-N 6-cat Chemical compound ClC1=CC=C2CC(N)CCC2=C1 CJRJTCMSQLEPFQ-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
• 108091093088 Amplicon Proteins 0.000 description 1
• 241000024188 Andala Species 0.000 description 1
• 241000219195 Arabidopsis thaliana Species 0.000 description 1
• DXHINQUXBZNUCF-MELADBBJSA-N Asn-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O DXHINQUXBZNUCF-MELADBBJSA-N 0.000 description 1
• 241000700663 Avipoxvirus Species 0.000 description 1
• WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 238000006222 Berchtold homologation reaction Methods 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108700016947 Bos taurus structural-GP Proteins 0.000 description 1
• 238000009010 Bradford assay Methods 0.000 description 1
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 102100023705 C-C motif chemokine 14 Human genes 0.000 description 1
• 102100023703 C-C motif chemokine 15 Human genes 0.000 description 1
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 1
• 101710112622 C-C motif chemokine 19 Proteins 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 108010075254 C-Peptide Proteins 0.000 description 1
• 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 1
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 1
• 101710098272 C-X-C motif chemokine 11 Proteins 0.000 description 1
• 102100039396 C-X-C motif chemokine 16 Human genes 0.000 description 1
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 1
• 101100377790 Caenorhabditis elegans aat-6 gene Proteins 0.000 description 1
• 101100324788 Caenorhabditis elegans atg-5 gene Proteins 0.000 description 1
• 101100439299 Caenorhabditis elegans cgt-3 gene Proteins 0.000 description 1
• 101100067649 Caenorhabditis elegans gta-1 gene Proteins 0.000 description 1
• 101100508408 Caenorhabditis elegans ifa-3 gene Proteins 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 108090000565 Capsid Proteins Proteins 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 108010082548 Chemokine CCL11 Proteins 0.000 description 1
• 108010082155 Chemokine CCL18 Proteins 0.000 description 1
• 108010083647 Chemokine CCL24 Proteins 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108010014419 Chemokine CXCL1 Proteins 0.000 description 1
• 102000016950 Chemokine CXCL1 Human genes 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 244000260524 Chrysanthemum balsamita Species 0.000 description 1
• 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
• IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
• 101710121366 Disintegrin and metalloproteinase domain-containing protein 11 Proteins 0.000 description 1
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 108010013369 Enteropeptidase Proteins 0.000 description 1
• 102100029727 Enteropeptidase Human genes 0.000 description 1
• 102100023688 Eotaxin Human genes 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 108091029865 Exogenous DNA Proteins 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
• 108090000378 Fibroblast growth factor 3 Proteins 0.000 description 1
• 102100028043 Fibroblast growth factor 3 Human genes 0.000 description 1
• 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 1
• 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 1
• 108090000380 Fibroblast growth factor 5 Proteins 0.000 description 1
• 102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
• 108090000382 Fibroblast growth factor 6 Proteins 0.000 description 1
• 102100028075 Fibroblast growth factor 6 Human genes 0.000 description 1
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
• 239000004606 Fillers/Extenders Substances 0.000 description 1
• 241000700662 Fowlpox virus Species 0.000 description 1
• 102000013818 Fractalkine Human genes 0.000 description 1
• 102100020997 Fractalkine Human genes 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108010001515 Galectin 4 Proteins 0.000 description 1
• 102100039556 Galectin-4 Human genes 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 241000219146 Gossypium Species 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 1
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 1
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 1
• 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 1
• 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 description 1
• 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 1
• 101000889133 Homo sapiens C-X-C motif chemokine 16 Proteins 0.000 description 1
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 1
• 101100382875 Homo sapiens CCL15 gene Proteins 0.000 description 1
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
• 101000930801 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 2 chain Proteins 0.000 description 1
• 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
• 101001123332 Homo sapiens Proteoglycan 4 Proteins 0.000 description 1
• 101000926206 Homo sapiens Putative glutathione hydrolase 3 proenzyme Proteins 0.000 description 1
• 101000632056 Homo sapiens Septin-9 Proteins 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 102000013264 Interleukin-23 Human genes 0.000 description 1
• 108010065637 Interleukin-23 Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 241000710912 Kunjin virus Species 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• 150000008575 L-amino acids Chemical class 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 206010024264 Lethargy Diseases 0.000 description 1
• 241000710769 Louping ill virus Species 0.000 description 1
• 102000043129 MHC class I family Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 108700005084 Multigene Family Proteins 0.000 description 1
• 241000282339 Mustela Species 0.000 description 1
• 208000008457 Neurologic Manifestations Diseases 0.000 description 1
• 206010060860 Neurological symptom Diseases 0.000 description 1
• 101100449516 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) grg-1 gene Proteins 0.000 description 1
• 206010067482 No adverse event Diseases 0.000 description 1
• 101800000512 Non-structural protein 1 Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 101150116130 ORF23 gene Proteins 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 102000004140 Oncostatin M Human genes 0.000 description 1
• 108090000630 Oncostatin M Proteins 0.000 description 1
• 101710149663 Osmotin Proteins 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 108020005120 Plant DNA Proteins 0.000 description 1
• 108010064851 Plant Proteins Proteins 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 241000282405 Pongo abelii Species 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
• 108010076181 Proinsulin Proteins 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 241001135314 Pseudoalteromonas espejiana Species 0.000 description 1
• 102100034060 Putative glutathione hydrolase 3 proenzyme Human genes 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
• 241000235070 Saccharomyces Species 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 102000039471 Small Nuclear RNA Human genes 0.000 description 1
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 229910000831 Steel Inorganic materials 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 241000271567 Struthioniformes Species 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
• 244000269722 Thea sinensis Species 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
• 230000010530 Virus Neutralization Effects 0.000 description 1
• 206010057293 West Nile viral infection Diseases 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 230000001594 aberrant effect Effects 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 208000026802 afebrile Diseases 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 239000002280 amphoteric surfactant Substances 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 238000002820 assay format Methods 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 229940125717 barbiturate Drugs 0.000 description 1
• HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
• 238000002869 basic local alignment search tool Methods 0.000 description 1
• 210000003323 beak Anatomy 0.000 description 1
• 235000015278 beef Nutrition 0.000 description 1
• 230000002457 bidirectional effect Effects 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 239000003181 biological factor Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
• 229920001400 block copolymer Polymers 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 229950004398 broxuridine Drugs 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 238000012832 cell culture technique Methods 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 208000037887 cell injury Diseases 0.000 description 1
• 230000010307 cell transformation Effects 0.000 description 1
• 229940030156 cell vaccine Drugs 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000001311 chemical methods and process Methods 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 239000013599 cloning vector Substances 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 229960002424 collagenase Drugs 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 238000002967 competitive immunoassay Methods 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000005138 cryopreservation Methods 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 235000021186 dishes Nutrition 0.000 description 1
• KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 230000006334 disulfide bridging Effects 0.000 description 1
• PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
• NLEBIOOXCVAHBD-QKMCSOCLSA-N dodecyl beta-D-maltoside Chemical compound O[C@@H]1[C@@H](O)[C@H](OCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NLEBIOOXCVAHBD-QKMCSOCLSA-N 0.000 description 1
• 238000011143 downstream manufacturing Methods 0.000 description 1
• 230000035622 drinking Effects 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 230000005684 electric field Effects 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 230000000408 embryogenic effect Effects 0.000 description 1
• 238000004945 emulsification Methods 0.000 description 1
• 238000012407 engineering method Methods 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 229960001483 eosin Drugs 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 229940014425 exodus Drugs 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 108010092809 exonuclease Bal 31 Proteins 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 238000009313 farming Methods 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 108700014844 flt3 ligand Proteins 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 238000004868 gas analysis Methods 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 238000012226 gene silencing method Methods 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 101150054900 gus gene Proteins 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 229940127121 immunoconjugate Drugs 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 239000002054 inoculum Substances 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 102000003898 interleukin-24 Human genes 0.000 description 1
• 108090000237 interleukin-24 Proteins 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 238000005304 joining Methods 0.000 description 1
• 210000004731 jugular vein Anatomy 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 108010019677 lymphotactin Proteins 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 238000003760 magnetic stirring Methods 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000001613 nuclear run-on assay Methods 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 229940023146 nucleic acid vaccine Drugs 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 230000000243 photosynthetic effect Effects 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 235000021118 plant-derived protein Nutrition 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 229910052697 platinum Inorganic materials 0.000 description 1
• 229920002492 poly(sulfone) Polymers 0.000 description 1
• 239000004417 polycarbonate Substances 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920000728 polyester Polymers 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
• 239000004810 polytetrafluoroethylene Substances 0.000 description 1
• 230000008092 positive effect Effects 0.000 description 1
• 238000012809 post-inoculation Methods 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 238000012808 pre-inoculation Methods 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 238000003751 purification from natural source Methods 0.000 description 1
• 238000011897 real-time detection Methods 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 239000012723 sample buffer Substances 0.000 description 1
• 239000012047 saturated solution Substances 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 108091029842 small nuclear ribonucleic acid Proteins 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 230000007928 solubilization Effects 0.000 description 1
• 238000005063 solubilization Methods 0.000 description 1
• 238000000638 solvent extraction Methods 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 238000011895 specific detection Methods 0.000 description 1
• 229960000268 spectinomycin Drugs 0.000 description 1
• 238000009987 spinning Methods 0.000 description 1
• 229940031439 squalene Drugs 0.000 description 1
• TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000003068 static effect Effects 0.000 description 1
• 239000010959 steel Substances 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 238000011146 sterile filtration Methods 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 230000004797 therapeutic response Effects 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 238000000844 transformation Methods 0.000 description 1
• 238000011426 transformation method Methods 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 238000005829 trimerization reaction Methods 0.000 description 1
• 229960001322 trypsin Drugs 0.000 description 1
• 239000006150 trypticase soy agar Substances 0.000 description 1
• WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
• 229910052721 tungsten Inorganic materials 0.000 description 1
• 239000010937 tungsten Substances 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 210000001364 upper extremity Anatomy 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 230000007485 viral shedding Effects 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 238000002424 x-ray crystallography Methods 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1